N-Terminal Plasmodium vivax Merozoite Surface Protein-1, a Potential Subunit for Malaria Vivax Vaccine
The human malaria is widely distributed in the Middle East, Asia, the western Pacific, and Central and South America. Plasmodium vivax started to have the attention of many researchers since it is causing diseases to millions of people and several reports of severe malaria cases have been noticed in...
Saved in:
Main Authors: | Fernanda G. Versiani, Maria E. Almeida, Luis A. Mariuba, Patricia P. Orlandi, Paulo A. Nogueira |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2013/965841 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IgM against Merozoite Surface Protein 1-Block 2 Haplotypes as New Tools for Plasmodium vivax Infections
by: Fernanda de Almeida Batalha, et al.
Published: (2024-12-01) -
Thrombocytopenia in Plasmodium vivax Malaria: How Significant?
by: Arti Muley, et al.
Published: (2014-01-01) -
Lipid Profile of Children with Malaria by Plasmodium vivax
by: Rosa Maria Dias, et al.
Published: (2016-01-01) -
Congenital Malaria due to Plasmodium Vivax Infection in a Neonate
by: Ravi Bhatia, et al.
Published: (2016-01-01) -
Genomic exploration of the journey of Plasmodium vivax in Latin America.
by: Margaux J M Lefebvre, et al.
Published: (2025-01-01)